Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients
about
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cellsAmniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsTelomere regulation in pluripotent stem cellsMolecular therapeutics for heritable skin diseasesThe genomic stability of induced pluripotent stem cellsProgramming and Reprogramming Cellular Age in the Era of Induced PluripotencyStem cell sources for vascular tissue engineering and regenerationModeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringMitochondrial rejuvenation after induced pluripotencyMitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrationsA balance between elongation and trimming regulates telomere stability in stem cellsCurrent Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium InternatiDigital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification.A common variant in the telomerase RNA component is associated with short telomere length.The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cellsInduced Pluripotent Stem Cells-A New Foundation in MedicineEffect of a qigong intervention program on telomerase activity and psychological stress in abused Chinese women: a randomized, wait-list controlled trial.Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming.The diagnosis and treatment of dyskeratosis congenita: a review.Female human iPSCs retain an inactive X chromosome.Generation of induced pluripotent stem cells from human kidney mesangial cellsTherapeutic opportunities: telomere maintenance in inducible pluripotent stem cells.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.The promise of induced pluripotent stem cells in research and therapyAging, rejuvenation, and epigenetic reprogramming: resetting the aging clock.Comparative angiogenic activities of induced pluripotent stem cells derived from young and old mice.TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells.The aging signature: a hallmark of induced pluripotent stem cells?Induced pluripotent stem cells in dermatology: potentials, advances, and limitationsNeuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds.Telomere elongation and naive pluripotent stem cells achieved from telomerase haplo-insufficient cells by somatic cell nuclear transfer.The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells.Aged iPSCs display an uncommon mitochondrial appearance and fail to undergo in vitro neurogenesis.Telomere reprogramming and maintenance in porcine iPS cells.Induced pluripotent stem cells for modelling human diseasesHuman endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells.Association of telomere length with authentic pluripotency of ES/iPS cellsDe novo generation of HSCs from somatic and pluripotent stem cell sources.Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.
P2860
Q24617599-DC86B18E-DD37-4D97-9AAF-37BC20B85922Q26750573-46AB2050-E1B2-4097-A3E5-C9317AA6C913Q26775122-154C54DF-980D-48F5-98BF-C2A2AE3B25FEQ26851428-F81CDA0E-855D-40E4-8263-29F5D39AB359Q26865551-ACA24A64-73FB-489D-81C8-838EA272E5A3Q26998764-6805A448-BBED-492E-A6D7-E2A6F2492AAEQ27008903-39440E4F-EE3F-4B9E-8FDE-F1F8CD864847Q27028106-4123D659-A5B1-4717-88F6-D162D9C7E6E0Q28083303-D70B43E2-9BDD-4EEE-BDDD-A1AEECFFC729Q28476352-CD334ED6-203E-4FDE-A052-20D26A999925Q28477951-25A7B284-F596-4513-986A-98C4CCA148FEQ28771742-10AE8DB2-C896-4F32-9A8E-15216FE1A3F2Q30238875-C679128E-D8C4-4528-AFD6-FD00B098B8F6Q33644453-F2B2975C-28AE-4128-A467-931B53E7A417Q33707480-FAFF904B-E23F-48E2-810F-052A6D27861CQ33741989-AE75FAAC-3B0E-4777-88D8-96025E541F97Q34031081-B2278D73-6C98-4467-9611-F604438FB07DQ34067550-04BF0181-5FC8-4F48-A754-C0460FB51D9EQ34076037-8C3B047A-9778-4E04-AC68-EA876859C69DQ34094121-08404AEF-9924-40A1-A492-F6460D47A56AQ34111572-7ED44480-B894-4106-873F-56138F244017Q34184650-A4B32BC1-BB92-4A29-BEFB-557F487DFA91Q34186790-5C264E1B-C3DC-4499-A633-7C3DBCE6B40CQ34231818-84A6E41E-2D9D-45FD-A55F-C8827D108A28Q34248218-2706F16A-51AE-4451-9F03-58B9067ECF5BQ34248727-E46A6ECF-28A3-459C-8746-868CA6A1E202Q34326261-45299496-33C2-4B86-8A6E-7650715638A3Q34348666-3B95E6D9-FA0B-4308-9065-D81A68B15638Q34386434-D4BE0EE8-8D5C-4002-A16B-1127DB60BEA1Q34400271-10936A3F-B5C1-4D4C-B092-82A3E9B17FBEQ34464236-65FCCD3A-A3FC-4F9C-B4A3-9D113118709BQ34715193-853E717A-E742-43AA-8623-DE018C3B350AQ34729447-FAD9F3CA-0B74-49A2-A109-A352CF00FB33Q34982517-D22958D1-1FDC-4108-B78B-7D0DD2B4241DQ35009829-656B2B75-9F3B-46F8-AE09-33A76C08A209Q35088519-63A4063C-5061-436F-BAC7-38C209B25001Q35416543-8F11E3A8-FE8E-44EB-AF50-CDDC732087C2Q35469233-8F62A249-FF33-4ECF-8B08-4B116642A295Q35533599-F4AFA852-C927-4C63-8000-ADCFCD5CC9E6Q35563251-1AFCD12D-1E74-4AD7-A10C-B3F4E9F49F3D
P2860
Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Telomere elongation in induced ...... yskeratosis congenita patients
@ast
Telomere elongation in induced ...... yskeratosis congenita patients
@en
Telomere elongation in induced ...... yskeratosis congenita patients
@nl
type
label
Telomere elongation in induced ...... yskeratosis congenita patients
@ast
Telomere elongation in induced ...... yskeratosis congenita patients
@en
Telomere elongation in induced ...... yskeratosis congenita patients
@nl
prefLabel
Telomere elongation in induced ...... yskeratosis congenita patients
@ast
Telomere elongation in induced ...... yskeratosis congenita patients
@en
Telomere elongation in induced ...... yskeratosis congenita patients
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Telomere elongation in induced ...... yskeratosis congenita patients
@en
P2093
David L Keefe
Erin M McLoughlin
Frederick D Goldman
Hongguang Huo
In-Hyun Park
Justine D Miller
Maja Okuka
Sabine Loewer
Suneet Agarwal
P2860
P2888
P3181
P356
10.1038/NATURE08792
P407
P577
2010-03-11T00:00:00Z
P5875
P6179
1005411330